Tan Lee Su-Leng
SEC insider (Form 3/4/5 filer). CIK 0002141883. Chief Executive Officer at BioNexus Gene Lab Corp (BGLC). 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 13, 2026. Located in KUALA LUMPUR.
Companies Tan Lee Su-Leng has filed insider reports for
- BioNexus Gene Lab Corp (BGLC): Director, Officer, 10% Owner, Chief Executive Officer
Tan Lee Su-Leng
CIK: 0002141883
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BGLC
BioNexus Gene Lab Corp
DirectorOfficer10% Owner